tm logo
AUVANEGY
REGISTERED

on 16 Aug 2024

Last Applicant/ Owned by

CLENE NANOMEDICINE INC.

6550 South Millrock Drive, Suite G50Salt Lake City UT 84121

US

Serial Number

2167394 filed on 14th Jan 2022

Registration Number

TMA1250922 registered on 16th Aug 2024

Registration expiry Date

14th Jan 2032

Correspondent Address

1 Place Ville Marie, Suite 4000Montréal

QUÉBEC

CA

H3B4M4

AUVANEGY

Trademark usage description

pharmaceutical preparations for the treatment of central nervous system diseases and disorders, namely, alzheimer's disease, parkinson's disease, hunt Read More

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of central nervous system diseases and disorders, namely, Alzheimer's disease, Parkinson's disease, Huntington's disease, multiple sclerosis, Friedreich ataxia, polyglutamine diseases, pharmaceutical preparations for the prevention and treatment of muscular atrophy, pharmaceutical preparations for the treatment and the prevention of dementia


Classification kind code

11

Class [044]
Providing information to healthcare professionals and patients regarding medical conditions and their treatment in the field of central nervous system disorders, diseases and pharmaceuticals


Classification kind code

11

Mark Details


Serial Number

2167394

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 22
on 05th Jun 2023
Search Recorded
Submitted for opposition 20
on 05th Jun 2023
Examiner's First Report
Submitted for opposition 223
on 05th Jun 2023
Total Provisional Refusal
Submitted for opposition 256
on 19th Dec 2022
Notification of Possible Opposition Sent
Submitted for opposition 48
on 08th Apr 2022
Agent Changed
Submitted for opposition 257
on 17th Feb 2022
Designation Notification - Madrid Protocol
Submitted for opposition 31
on 17th Feb 2022
Formalized
Submitted for opposition 1
on 17th Feb 2022
Created
Submitted for opposition 228
on 14th Jan 2022
International Registration
Submitted for opposition 30
on 14th Jan 2022
Filed